AmbioPharm was founded in 2006 and is one of the largest peptide manufacturers in the world. With FDA-inspected facilities in North Augusta, South Carolina, USA, and in Shanghai, China, we employ more than 500 experienced peptide chemists and industry professionals. AmbioPharm has developed a unique CDMO business model designed to handle all types of peptide manufacturing and can handle a project of any scale, from research to cGMP.